Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Date: 11/6/2020

Budget: $5,000,000

Opportunity: PAR-18-497

This FOA is aimed at molecular, cellular, genetic, epigenetic, and systems biology approaches to advance basic and clinical research on the causes and consequences of sleep deficiency and circadian clock dysfunction in Alzheimer’s disease, and the roles of sleep and the circadian clock as modifiers of the progression of neurodegeneration.

Leave a Reply